The Hope Foundation is honored to provide fellowships and grants, educational programs, group meeting support, and professional development for SWOG‘s network of cancer researchers and patient advocates.
The SWOG/Hope Impact Award Program
The SWOG/Hope Impact Award is a funding program that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects.
Secondary Data Analysis
Secondary Data Analysis Projects strive to connect SWOG researchers with the statistical support required to conduct database analyses using SWOG clinical trials data alone or in combination with registry or claims data, or other potential linkages.
SWOG Early Exploration and Development (SEED) Fund
Awards are made from The Hope Foundation for Cancer Research SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).
SWOG Integrated Translational Science Center (ITSC) Pilot Awards
The purpose of the SWOG ITSC Pilot Awards program is to stimulate collaborative translational research among CSHL, JAX and SWOG investigators with the objective of rapidly integrating promising preclinical approaches into ongoing and future clinical trials.
SWOG Trial-Specific Education Funds
A program offered to support the provision of education and training for sites participating in complex SWOG trials. Studies that are deemed to have non-standard endpoints, complicated design, and/or registration potential are eligible for up to $5,000.
SWOG Trial Support (STrS)
STrS awards are provided to support components of approved and activated studies that require additional funding during patient enrollment.
SWOG Grant Writing Workshop
This virtual grant-writing workshop is designed for new and young investigators preparing for future grant submissions, including career development awards (i.e., K awards, K equivalents) and pilot/research grants (i.e., R03, R21, etc.).
Dr. Charles A. Coltman, Jr., Fellowship Program
The primary purpose of the Dr. Charles A. Coltman, Jr., Fellowship is to engage outstanding early career investigators from SWOG-affiliated institutions in learning clinical trial methodology within an academic and network group environment that will lead to independent clinical research.
Career Engagement Award
To ensure protected time for mid-career investigators from SWOG-affiliated institutions to pursue clinical research initiatives. Provided as salary support over 2 years.
Young Investigator Training Course
The Young Investigator Training Course is three full days of protocol development, trial management, and statistical analysis – topics identified by seasoned and new researchers alike as areas of specific concern to those entering the field.
SWOG Leadership Academy
The SWOG Leadership Academy engages the best and brightest of the Group’s early career investigators to prepare them for future leadership within the NCTN.
SWOG Committee Group Meeting Funds
SWOG disease, research, and administrative committee chairs are provided the opportunity to request up to $15,000 annually to support committee efforts at Group Meetings not currently funded by the NCTN or NCORP grants.
SWOG CRA/Nurse Travel Support Program
Funding available for CRAs/nurses to travel to SWOG group meetings annually.
SWOG Board of Governors Travel Support Program
Funding provided for the travel of current members of the SWOG Board of Governors in order to facilitate participation in the SWOG BOG and Group Meeting each spring and fall.
VA Integration Support Program
Awards from the SWOG/Hope VA Integration Support Program support Veterans Health Administration Medical Centers’ efforts to start or to significantly improve their participation in oncology clinical trials within the NCTN.
The Sunshine Act
The Physician Payments Sunshine Act passed as part of the Patient Protection and Affordable Care Act in 2010. The law is designed to bring transparency to financial relationships between physicians, teaching hospitals, and the pharmaceutical industry. This is pertinent to The Hope Foundation because we receive donations from manufacturers who are required to pass reporting obligations on to the third party charitable organizations that they support.
The Hope Foundation is not required to make any direct reports to the government as a result of The Sunshine Act. However, The Foundation is required to report to certain funders who support our programs. These funders are manufacturers bound by the reporting regulations, whose charitable donations to the Foundation may support travel, meals or research for grantees who are US licensed physicians. With the Sunshine Act, payments or transfers of value made to physicians indirectly through a charitable organization must be reported if the manufacturer knows that money will be paid to physicians or earmarks money to go to physicians. At Hope, this is the scenario for many of our restricted donations.